Effects of Psychological and Lifestyle Factors on Metabolic Syndrome Following the Fukushima Daiichi Nuclear Power Plant Accident: The Fukushima Health Management Survey.
Disaster
Lifestyle
Metabolic syndrome
Post-traumatic stress disorder
Journal
Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298
Informations de publication
Date de publication:
01 Sep 2020
01 Sep 2020
Historique:
pubmed:
6
2
2020
medline:
13
7
2021
entrez:
4
2
2020
Statut:
ppublish
Résumé
The Fukushima Daiichi Nuclear Power Plant accident dramatically changed the lifestyle of residents who lived near the plant. We evaluated the association of metabolic syndrome (MetS) with specific lifestyle- and disaster-related factors in residents following the accident. This cross-sectional study included 20,920 residents who underwent both the Comprehensive Health Check and the Mental Health and Lifestyle Survey from June 2011 to March 2012. Associations between MetS and lifestyle- and disaster-related factors, including psychological distress (post-traumatic stress disorder [PTSD]), were estimated using logistic regression analysis, adjusted for demographic and lifestyle factors, in 2019. MetS was present in 30.4% of men and 11.5% of women. There were significant differences in smoking, drinking status, and PTSD prevalence between subjects with and without MetS. Multivariable logistic regression analysis showed that age, quitting smoking, and low physical activity were significantly associated with MetS. Moreover, PTSD and light to moderate drinking were also significantly associated with MetS in women. Lifestyle- and disaster-related factors, including PTSD, were associated with MetS among subjects who lived near the Fukushima Daiichi Nuclear Power Plant accident.
Identifiants
pubmed: 32009075
doi: 10.5551/jat.52225
pmc: PMC7508722
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1010-1018Références
J Epidemiol. 2012;22(5):375-83
pubmed: 22955043
Ann N Y Acad Sci. 1999 Jun 22;876:102-17; discussion 117-8
pubmed: 10415599
Diabetes Res Clin Pract. 2007 Nov;78(2):217-24
pubmed: 17448561
N Engl J Med. 1991 Mar 14;324(11):739-45
pubmed: 1997840
Am J Prev Med. 2016 May;50(5):553-560
pubmed: 26673483
Clin Nutr. 2014 Aug;33(4):596-602
pubmed: 24315622
Psychol Med. 2014 Jul;44(10):2017-28
pubmed: 24262678
J Atheroscler Thromb. 2016 Nov 1;23(11):1270-1275
pubmed: 27298048
BMJ Open. 2018 Jun 30;8(6):e018943
pubmed: 29961000
Neuropsychopharmacology. 1999 Jul;21(1):40-50
pubmed: 10379518
Environ Health Perspect. 2008 Sep;116(9):1248-53
pubmed: 18795171
PLoS One. 2016 Dec 20;11(12):e0168503
pubmed: 27997601
Medicine (Baltimore). 2018 Oct;97(42):e12890
pubmed: 30335013
Cell Mol Neurobiol. 2012 Jul;32(5):709-23
pubmed: 22488525
Metabolism. 2015 Aug;64(8):926-33
pubmed: 25982700
Biomed Pharmacother. 2019 Sep;117:108834
pubmed: 31177066
Fukushima J Med Sci. 2014;60(1):57-67
pubmed: 25030715
J Atheroscler Thromb. 2018 Jan 1;25(1):90-97
pubmed: 28592705
J Atheroscler Thromb. 2017 Mar 1;24(3):327-337
pubmed: 27629253
BMJ Open. 2016 Jul 05;6(7):e011534
pubmed: 27381210
Int J Methods Psychiatr Res. 2008;17(3):152-8
pubmed: 18763695
Hypertension. 2016 Sep;68(3):558-64
pubmed: 27480836
Arch Gen Psychiatry. 2003 Feb;60(2):184-9
pubmed: 12578436
J Clin Epidemiol. 2003 Feb;56(2):196-204
pubmed: 12654415
Atherosclerosis. 2009 Jun;204(2):624-35
pubmed: 19084839
J Clin Epidemiol. 2012 Nov;65(11):1181-9
pubmed: 22906867
J Atheroscler Thromb. 2005;12(6):301
pubmed: 16394611
J Diabetes Res. 2015;2015:627390
pubmed: 26106625
Diabetes Care. 2005 Mar;28(3):719-25
pubmed: 15735217
Intern Med. 2016;55(15):1967-76
pubmed: 27477401
Metabolism. 2004 Nov;53(11):1503-11
pubmed: 15536610
Schizophr Bull. 2013 Mar;39(2):306-18
pubmed: 22207632
Int J Environ Res Public Health. 2017 Oct 24;14(10):
pubmed: 29064443
Alcohol Clin Exp Res. 2002 Jul;26(7):1010-6
pubmed: 12170111
PLoS One. 2012;7(2):e17061
pubmed: 22879858
Asia Pac Psychiatry. 2017 Mar;9(1):
pubmed: 27505724
J Epidemiol. 2017 Apr;27(4):180-185
pubmed: 28142046
Neuropsychopharmacology. 2003 Sep;28(9):1656-65
pubmed: 12838270